The Lustgarten Foundation announces two new pancreatic cancer research laboratories through respective partnerships with Dana-Farber Cancer Institute and Massachusetts Institute of Technology (MIT).
Let’s Win! Pancreatic Cancer Foundation is the inaugural winner of the Biden Cancer Initiative FIERCE Award for “Leadership through Exemplary and Awesome Purpose (LEAP).”
Let’s Win and the Elvin Howard, Sr. Pancreatic Cancer Advocacy Foundation join in mourning Aretha Franklin, and to raise awareness of pancreatic cancer.
Let’s Win’s Dr. Allyson Ocean spoke to FiOS1 News (Lower Hudson Valley) about pancreatic cancer and the death of Aretha Franklin.
Camille Moses traveled to Washington, D.C., with Julie Fleshman from PanCAN to urge Congress to provide more funding for pancreatic cancer research.
Dr. Brian Wolpin has found that about 1/3 of pancreatic cancer patients may benefit from genetic sequencing to determine treatment.
An international team of researchers led by Dr. David Tuveson has found that organoids can predict how pancreatic cancer patients will respond to different treatments.
The Lustgarten Foundation and Stand Up To Cancer have joined forces for a research partnership called the Pancreatic Cancer Collective.
Dr. David Tuveson has been appointed the chief scientist for the Lustgarten Foundation. He specializes in pancreatic cancer reseach at the Cold Spring Harbor Labs.
Dr. Allyson Ocean, Chair of the Let’s Win Scientific Advisory Board, discusses the role of vitamin D in the stroma of pancreatic tumors.